




Searching News Database: PROCHYMAL
HSMN NewsFeed - 14 Jan 2014
Osiris Therapeutics Board Confirms Lode Debrabandere, PhD, MBA, as President and Chief Executive Officer
Osiris Therapeutics Board Confirms Lode Debrabandere, PhD, MBA, as President and Chief Executive Officer
HSMN NewsFeed - 8 Sep 2009
Osiris Therapeutics Announces Preliminary Results for Prochymal Phase III GvHD Trials
Osiris Therapeutics Announces Preliminary Results for Prochymal Phase III GvHD Trials
HSMN NewsFeed - 12 Feb 2009
Osiris Reports Positive Two-Year Data on Stem Cell Treatment for Acute Myocardial Infarction
Osiris Reports Positive Two-Year Data on Stem Cell Treatment for Acute Myocardial Infarction
HSMN NewsFeed - 15 Jan 2009
Osiris Receives FDA Clearance to Broaden Prochymal Expanded Access Program
Osiris Receives FDA Clearance to Broaden Prochymal Expanded Access Program
HSMN NewsFeed - 15 Jan 2009
Osiris and FDA Reach Agreement on Submission of First Marketing Application for a Stem Cell Product
Osiris and FDA Reach Agreement on Submission of First Marketing Application for a Stem Cell Product
HSMN NewsFeed - 8 May 2008
Osiris Receives Approval for Use of Prochymal(TM) Under FDA Expanded Access Treatment Program
Osiris Receives Approval for Use of Prochymal(TM) Under FDA Expanded Access Treatment Program
HSMN NewsFeed - 7 Jan 2008
Osiris Therapeutics Regains Worldwide Rights to Cardiovascular Indications for Prochymal(TM)
Osiris Therapeutics Regains Worldwide Rights to Cardiovascular Indications for Prochymal(TM)
HSMN NewsFeed - 27 Nov 2007
Osiris Therapeutics Announces Positive One Year Data from Chondrogen Trial for Knee Repair
Osiris Therapeutics Announces Positive One Year Data from Chondrogen Trial for Knee Repair
HSMN NewsFeed - 9 Oct 2007
Osiris Therapeutics Secures $30 Million Financing Commitment from Chairman and Largest Shareholder
Osiris Therapeutics Secures $30 Million Financing Commitment from Chairman and Largest Shareholder
Additional items found! 8

Members Archive contains
8 additional stories matching:
PROCHYMAL
(Password required)
PROCHYMAL
(Password required)